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Rex protein, the posttranscriptional regulator
of huHTLV-I’ is an etiological agent for adult T-cell leukemia
man T-cell leukemia virus type I (HTLV-I),is required (9, 10). HTLV-I contains a unique regulatory gene, termed
for the control of viral structural protein expression p X , that encodes three proteins, Tax, Rex, and pp21 (11-15).
and virus replication. Rex is a phosphoprotein found Tax is known to activate transcription of the virus (16-18)
predominantly in the cell nucleolus, whose functionis and several cellular genes (19-21). Rex is a posttranscriptional
thought to be regulated by
its nucleolar localization regulator that induces the accumulation of unspliced viral
and phosphorylation. Therefore, we investigated the gag-pol mRNA (4, 5, 22, 23). Rex is a phosphoprotein found
in vivophosphorylation of Rex protein in more
detail. predominantly in the cell nucleolus, whose function may be
Phosphorylation of Rexoccurredin all HTLV-I-in- regulated by its nucleolar localization (24) and phosphorylafected cell lines examined in vivo,primarily at serine tion (4,5). Actually, dephosphorylation of Rex results in the
residues and to a very small extent at threonine residues. Treatment ofcells with 12-O-tetradecanoylphor- decrease of accumulation of unspliced viral mRNA (4).
We were therefore interested in investigating in detail the
bol-13-acetate (TPA) led to significant but transient
in
uiuophosphorylation of Rex protein. For this purpose, we
enhancement of the incorporation of [32P]orthophosphate into Rex protein. N-terminal truncationof Rex isolated 32P-labeledRex from HTLV-I-infected human T-cell
lines by immunoprecipitation, performed various biochemical
proteinabolishedTPA-dependentphosphorylation.
analyses, and determined the phosphorylation sites within
Chymotryptic digestion of phosphorylated Rex yielded
two phosphopeptides. In vivo phosphorylation sites the Rex molecule.
were identified as serine residues 70 and 177 and
EXPERIMENTALPROCEDURES
threonine residue 174. Serine 70 was a TPA-dependent phosphorylation site within a regulatory domain.
Cells and Metabolic Labeling-HUT-102, MT-2, and TL-Su (25)
We have already shown that the protein kinase C in- are human T-cell lines infected with HTLV-I. TART-1 (26) is an
hibitor H-7 (l-(5-isoquinolinylsulfonyl)-2-methylpi- HTLV-I-infected rat T-cellline. Cell lines CCRF-CEM, Jurkat, and
perazine) specifically blockedaccumulationof viral Molt-4 (25) are uninfected human T-celllines. Cell lines Raji and Kunspliced gag-pol mRNA. Therefore, the phosphoryl- 562 (25) are human lymphoblast-like cells and erythroleukemia cells,
ation at serine 70 may beinvolved in the regulationof respectively. All cell lines were routinely maintained in RPMI 1640
medium supplemented with 10%fetal calf serum (heat-inactivated at
Rex function in response toextracellular stimuli.

Protein phosphorylation is believed to be a major general
mechanism by which external physiological stimuli affect
intracellular events in eukaryotic cells (1-3). Studies of the
effect of phosphorylation on protein function have focused
primarily on cell surface receptors and cytoplasmic proteins.
However, it is clear that many nuclear proteins, including
proteins thought to be involved in gene regulation, are also
phosphorylated in vivo (1, 4-8).It therefore appears possible
that the variable phosphorylation of these trans-acting regulatory proteins has functional consequences for the regulation
of cellular or viral gene expression and may, in fact, constitute
one mechanism by which nuclear events are modulated by
external stimuli (1, 8).

* This work was supported in part by grants from the Mochida
Memorial Foundation for Medical and Pharmaceutical Research, by
grants-in-aid for scientific and cancer research from the Ministry of
Education, Science and Culture of Japan, andby the NationalCancer
Institute, Departmentof Health and HumanServices under Contract
N01-CO-74101. The costs of publication of this article were defrayed
in part by the payment of page charges. This article must therefore
be hereby marked“advertisement” in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
ll To whom correspondence should be addressed.

56 “C for 30 min) at37 “C in humidified air with 5% CO,. COS-7 cells
(5) were grown in Dulbecco’s modified Eagle’s medium supplemented
with10%fetal
calf serum. Metabolic labeling of cells with [”PI
orthophosphate (18.5 MBq/ml) was conducted by incubating cells (1
X lo6 cells/ml) in phosphate-free medium supplemented with 10%
fetal calf serum dialyzed against Tris-buffered saline (20 mM TrisHC1, 0.15 M NaCl, pH 7.5) at 37 “C for 2 h with various stimulations
as previously described (27). At the end of the incubation period, cells
were washed with phosphate-buffered saline (10 mM phosphate, 0.14
M NaCl, pH 7.5).
Antibody Preparation-Rabbits were immunized by injection of
thesynthetic peptide NH2-Thr-Ser-Phe-Pro-Pro-Pro-Ser-Pro-GlyPro-Ser-Cys-Pro-Thr-COOH corresponding to the C-terminal region
of HTLV-I Rex in complete Freund’s adjuvant. An immunoglobulin
G (IgG) fraction of antiserum was prepared as described previously
(27) and used in this study.
Immunoblot Analysis-Proteins from each cell extract were subjected to SDS-PAGE on 12.5% polyacrylamide gels according to the
procedure of Laemmli (28). Separated proteins were transferred onto
nitrocellulose membrane and incubated with anti-Rex IgG. The im-

’ The abbreviations used are: HTLV-I, human T-cell leukemia
virustype
I; TPA, 12-O-tetradecanoylphorbol-13-acetate;
PAGE,
polyacrylamide gel electrophoresis; TPCK, L-l-p-tosylamino-2-phenylethylchloromethyl
ketone; TLCK, 5-amino-~-tosylaminopentyl
chloromethyl ketone; HPLC, high-pressure liquid chromatography;
db-CAMP, W-2’-O-dibutyryladenosine 3’:5’-cyclic monophosphate;
db-cGMP, NG-2’-O-dibutyrylguanosine3’:5’-cyclic monophosphate;
kb, kilobase(s); PVDF, polyvinylidene difluoride; HIV-1, human immunodeficiency virus type 1.
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munocomplexes were detected by binding with horseradish peroxiM 1 2
3 4 5 6 7 8
dase-conjugated protein A as described previously (25).
92.5Immunoprecipitation-metabolic all^^ labeled cells were lysed with
RIPAbuffer (50 mM Tris-HCI, 0.15 M NaCI,4 mM EDTA, 1rO
68Nonidet P-40, 0.1% sodium deoxycholate, 10
mM Na4P20:, 10 mM
NaF, 2 mM Na:$VO:,,1 mM phenylmethvlsulfonvl fluoride, p H 7 . 5 ) a t
434 "C for 30 min.Aftercentrifugation
at 15,000 rpm(Eppendorf
microcentrifuge) for 10 min, the supernatant was incubated with antiRex IgG at 4 "C for 2 h. The immunocomplexes were precipitated
with protein A-Sepharose CL-4B, then extensively washed with RIPA
25.7-Rex
buffer and LSW huffer (10 mM Tris-HCI, 10 mM NaCI, pH 7.6) as
described previously (27). The immunoprecipitates were subjected to
SDS-PAGE. After electrophoresis,gels were stained with Coomassie
18.4Brilliant Blue R-250, dried, and subjected to autoradiography using
a n intensifying screen.
FIG. 1. Detection of Rex in HTLV-I-infected human T-cells.
Phosphoarnino Acid Ana!\mis-'"P-Labeled Rex protein was eluted
Cell extracts (120pg of protein in every case) were analyzed by SDSfrom acrylamide gel sections by TPCK-trypsin digestion (50 pg/ml)
in 50 mM NH,HCO:,. Recovered pbosphopeptides were hydrolyzed in PAGE followed by immunoblotting with antibody to the C terminus
6 N HCI at 105 "Cfor 2 h. Resulting phosphoamino acid samples were of Rex as described under "Experimental Procedures." LaneI , HUT102; lane 2, MT-2; lane 3, Jurkat; lane 4 , Molt-4; lane S, TL-Su; lane
mixed with standards (phosphoserine, phosphothreonine, and phos6, TART-1; lane 7, Raji; lane 8, K-562. Molecular size standards (in
photyrosine; 5 pg each) and applied onto cellulose-coated thin-layer
glass plates (20 X 20 cm). High voltage electrophoresis was performedkilodaltons) are indicated on theleft.
in pH 3.5 buffer (pyridine:acetic acid:water, 1:10:189 (v/v)) at 4 "C.
"T-Labeled phosphoamino acidswere identified by autoradiography,
M 1 2 3 4
11 121314151617 18
and phosphoamino acid standards were identified by spraying the
plates with ninhydrin (27).
DNA Transfection-Rex expression vector pKCR27+40X was con45"
structed by inserting a 1.1-kt) BamHI/SrnaI fragment (nucleotides
5095-8308) of p X cDNA from pHA27X (24) into the same sites of
pKCROHS(29). Deletion mutantpKCR21Xwasconstructed
by
31inserting a RalI fragment (nucleotides 7437-8091) of XHTLVIC (30)
-Rex
into an HindIII siteof pKCRH2 (31)by using HindIII linkers. COS7 cells were transfected with plasmid DNAby the calcium phosphate21.5precipitation method (5).
Endoproteinase Digestion and HPLC Seppnrpntion-TLCK-chymo14.4trypsin wasused for digestion of :"P-labeled Rex on Immobilon PVDF
FIG. 2. In vivo phosphorylation of Rex. Cells were metabolimembrane (Millipore). Digestionswere carried out at 37 "C in .50 mM
NH,HCO,, for 4 h followed by overnight incubation with a second cally labeled with [''YP]orthophosphate, lysed, and subjected to immunoprecipitation with anti-Rex IgG as describedunder"Experiidentical doseof proteinase. The sample after digestion was subjected
t o reversed-phase HPLC using
a CIS column (0.46
X 15 cm, Separation mental Procedures." The cell lines examinedwere CCRF-CEM (lanes
1 and 2 ) , HUT-102 (lanes 3 and 4 ) , Molt-4 (lanes 5 and 6 ) , MT-2
Group). The elution was performed by a linear gradient of0-6596
(lanes 7 and 8 ) , Jurkat (lanes 9 and I O ) , TL-Su (lanes I 1 and 12).
solvent B for 70 min (solvent A: 0.1% trifluoroacetic acid in water;
Raji (lanes 13 and I d ) , TART-1 (lanes 1.5 and 16), and K-562 (lanes
solvent R: 0.1% trifluoroacetic acid in acetonitrile).
17 and 18). Samples in euen-numbered lanes were pulsed wit,h 100
Radiosequencing-Each
phosphopeptide
from
reversed-phase
h labeling. Samples in odd-numbered
HPLC was subjected to sequential Edman degradation in
a Reckman ng/ml TPA for 15 min after 2 of
was
89OC automatedspinningcupsequenatorwith10nmol
of horse lanes were not subjected to TPA treatment. Autoradiography
apomyoglobin (Sigma) carrier as described previously
(82). Fractions carried out for 24h. Molecular size standards (in kilodaltons) are
indicated on the left.
collected at each cycle of sequentialanalysisweretransferredto
scintillationvials,driedwith
N, andheat,redissolvedin
8 ml of
Aquasure (Du Pont-New England Nuclear), and allowed to equiliionophore ALI:,IH7
are known to activatecellular protein kinase
brate in the dark for 2 h, and scintillation was counted.
C (1, 33). Forskolin and db-CAMP are activatorsof adenylate
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cyclase and proteinkinase A (27),respectively. Protein kinase
G is known to be activated by db-cGMP (27). The HTLV-II n Vivo Phosphorylation of HTLV-I Rex-The Rex protein infected cell lines TL-Su and HUT-102were pulsed with 100
encoded by the HTLV-Ip X gene open reading frame consists ng/ml TPA, 10 FM forskolin, 0.5 mM db-CAMP, or 0.5 mM
of 189 amino acids and has a molecular mass of 27 kDa. As db-cGMP for 15 min at the end of the "'P-labeling period,
shown in Fig. 1, all of the HTLV-I-infectedcell lines that we and '"P-labeled Rex was immunoprecipitated. As shown in
tested(HUT-102,MT-2,TL-Su,andTART-1)
expressed Fig. 3, the incorporation of :"Pi into Rex was preferentially
nearly the same amount of Rex protein. When the human
and rapidly augmented by TPA-treatment but not by treathematopoietic cell lines were metabolically labeled with ['"PI ment with any otherdrugs. By contrast, noincreased syntheorthophosphate for 2 hand subjected to immunoprecipitation, sis of Rex protein was observed during 15-mindrug treatment
the radioactive Rex protein was specifically observed in the (data not shown). Quantification of the resultant autoradiHTLV-I-infected cell lines (Fig. 2).In these cell lines, slightly ograms by densitometric scanning revealed an approximate
limited proteolysis or microheterogeneity of labeled Rex was &fold increase of Rex phosphorylation in the TPA-treated
observed. The incorporation of :"Pi into the Rex protein was cultures relative to the control or to other treatments.
enhanced approximately 5-fold when the cells were pulsed
Effect of Down-regulation of Protein Kinase C on Rex Phoswith 100 ng/ml TPA for 15 min at the end of ""P-labeling phorylation-Stimulation of cells with TPA appears toresult
period. Since the radioactivity associated with Rex was sen- in rapid translocation of protein kinase C from the cytosol to
sites within the membrane. However, this activated memsitive for thealkalinephosphatasetreatment(datanot
shown), incorporation of the radioactivity was due to protein brane-associatedprotein kinase C is rapidly degraded by
nonlysosomal proteolysis, leading to a subsequent rapid dephosphorylation, but notADP-ribosylation.
Effects of Drugs on Phosphorylation ofRex-To
explore cline in kinase activity (down-regulation) (34,35). In order to
which protein kinases are involved in the phosphorylationof confirm the possible involvement of protein kinase C on Rex
Rex in vivo, we examined the effects of various drugs on its phosphorylation, we caused the down-regulation of cellular
phosphorylation. The phorbol ester TPA and the
calcium protein kinase C by long-term exposure to TPA and moniRESULTS
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FIG.3. Effect of drugs on
phosphorylation of Rex. Cells were
labeled with [''T]orthophosphate for2 h, then incubated with various
drugs at optimumconcentrationsfor15min
as describedunder
"Experimental Procedures." Cell extracts were immunoprecipitated
'P-Tyr
with anti-Rex IgG and analyzed by SDS-PAGE followed by autoradiography. The cell lines examined were TL-Su ( A ) and HUT-102
FIG.5 . Phosphoamino acid analysis of Rex.A, '9-labeled Rex
( H ) . Lane 1, no stimulation; lone 2, 100 ng/ml TPA: lane 3 , 10 PM
A2:~~s:;
lane 4 , 10 P M forskolin; lane 5 , 0.5 mM dh-CAMP; lane 6, 0.5 protein from various HTLV-I-infected human T-cells was immunomM d h - G M P . Molecular size standards (in kilodalton) are indicated precipitated, eluted from gels, and hydrolyzed in 6 N HCI at 105 "C
for 2 h. Phosphoamino acids were separatedby high voltage electroon the left.
phoresis and suhjected
ho autoradiography. Rex proteins were isolated
from MT-2 (lanes 1 and 2), HUT-102 (lanes 3 and 4 , TL-SU (lanes
A
B
5 and 6), and TART-1 (lanes 7 and X ) . Samples in lanes 2,4, 6, and
M
1 2 3 4
M 1 2 3 4
8 were treated with TPA for15 min after the laheling period. Samples
92.5- C C "W
in lanes 1, :I, 5 , and 7 were labeled without TPA treatment. H , ,i'I'labeled Rex proteins from drug-treatedHUT-102 (lanes 1-6) and
66.2TI,& (lanes 7-12) were subjected to phosphoamino acid analysisas
described ahove. Lanes 1 and 7, no treatment; lanes 2 and X , 100 ng/
45ml TPA; lanes 3 and 9,10 PM AL':31X;;
lanes iland 10, 10 PM forskolin;
Lanes 5 and 1I , 0.5 mM db-CAMP; lanes 6 and 12, 0.5 mM dh-cGMP.
"
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FIG.4. Effect of down-regulation of protein kinase C on
phosphorylation of Rex. Cell lines HUT-102 ( A ) and TL-Su ( 8 )
were preincuhated overnight in the absence (lanes 1 and 2) or presence (lanes 3 and 4 ) of 200 ng/ml TPA, then incubated with ['"P]
orthophosphatefor 2 h as describedunder"Experimental
Procedures." In lanes 2 and4 , samples were incubated with 100 ng/ml
TPA
for 15 min after the labeling period. In lanes 1 and 3,samples were
labeled without TPA treatment. Cell extracts were immunoprecipitated with anti-Rex IgG and analyzed by SDS-PAGE followed by
autoradiography. Molecular size standards (in kilodaltons) are indicated on the left.

tored thephosphorylation of Rex after retreatmentwith TPA.
TPA-dependent enhancement of Rex phosphorylation was
observed in the absence of pretreatment with TPA (Fig. 4 A ,
lanes 1 and 2). By contrast, the phosphorylationof Rex was
no longer dependent on TPA after extensive pretreatment
with TPA (lanes 3 and 4 ) . However, TPA-independent and
basal phosphorylation of Rex, which corresponds to thecontrol, was still detectable. Similar resultswere also observed in
another HTLV-I-infected cell lines, TL-Su (Fig. 4B).Thus,
a part of Rex phosphorylation was closely relatedtothe
activation of protein kinase C.
Phosphoamino Acid Analysis of Rex-To identify the phosphorylated amino acids present in Rex, '"P-labeled Rex proteins from various HTLV-I-infected cells and drug-treated
cells were eluted from gel sectionsand subjected to acid
hydrolysis. Phosphoamino acids were separated by electrophoresis and detected by autoradiography. As shown in Fig.
5 , in all HTLV-I-infected cells ( A ) and all drug treatments
( R ) ,the Rex protein was phosphorylated mainly at the serine
residuewith traceamounts of phosphothreonine in uiuo.
However, phosphotyrosine was not detectable in any of the
cells and treatments examined.
Phosphorylation of Truncated Rex, pp21"The objectives of

..

p-

- - imml.(

pKCRH2

-

Hxndlll

~

Hmdlll

FIG.6. Schematic presentation of Rex expression plasmid
and deletion mutant. pKCR27+40X in which p X cDNA was inserted downstream of the simian virus 40 early promoter, encodes
full-size Rex. The exon and intron sequences of the rahhit /j-glohin
gene are indicated hy solid boxes. pKCR21X, which produces pp21,
was constructedby deleting the first78 amino acidsof Rex. pKCIIH2
is the original vector used for construction of the ahove plasmids.

M

31-

21.5-

1 2 3 4 5 6

-Rex
-PP21

14.4-

FIG.7 . Phosphorylation ofRex and pp21 in transfected
COS-7 cells. The products of Rex expression vector (pKCK27+40S:
lanes 1 and 2), deletionmutant (pKCR'21X: 1onc.s 3 and 4 ) , and
negative control (pKCRH2: lanes 5 and 6 ) were immunoprecipitated
from '"P-labeled cell lysates after parallel DNA-transfection. Samples
in lanes 2, 4 , and 6 were incuhated with TPA for 15 min after 2 h of
labeling.Samplesin
lnnes 1, 3 , and 5 were laheled without TPA
treatment. Molecular size standards (in kilodaltons)
are indicated on
the left.
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FIG. 10. In vivo phosphorylation sites of HTLV-I Rex. Arrows mark the sites of efficient chymotryptic cleavage. Brackets
indicate chymotryptic phosphopeptides, identified by the numbering
system of Fig. 8. Circled residues are phosphorylated in uiuo. The
consensus sequence of the site phosphorylated by protein kinase C is
marked with a wavy underline.The antigenic sequence of the antibody
used in this study is underlined.
Fraction Number

FIG. 8. Purification of chymotryptic phosphopeptides by
Cle reversed-phase HPLC. 32P-LabeledRex was prepared by immunoprecipitation and SDS-PAGE, then digested with TLCK-chymotrypsin as described under “Experimental Procedures.” The resulting peptides were applied onto a Cls column (0.46 x 15 cm). The
phosphopeptides were separated at a flow rate of 1.0 ml/min with a
linear gradient of 0-65% acetonitrile in 0.1% trifluoroacetic acid as
shown by the dashed line. The radioactivity in each fraction was
monitored by Cerenkov counting.

immunoprecipitation followed by SDS-PAGE and autoradiography. As shown in Fig. 7, the Rex protein expressed by
pKCR27+40X was phosphorylated in vivo, and TPA-dependent phosphorylation was also observed in COS-7 cells. The
deletion of the first 78 amino acid residues of Rex caused a
significantdisappearance of TPA-dependent phosphorylation. However, phosphorylation of pp21, which corresponds
to the basal level of TPA-independent phosphorylation was
still observed. Hence, TPA-dependent site(s) are located in
the 78 N-terminal amino acid residues, and another site(s)is
100
A
located in residues 79-189 of Rex.
Identification of in Vivo Phosphorylation Sites of Rex-In
Peak 1
order to determine the precise location of the phosphorylated
serine(s) and threonine(s), we prepared 32P-labeled Rex by
metabolic labeling followedby immunoprecipitation. After
extensive digestion with TLCK-chymotrypsin, the resulting
peptides were separated by HPLC (Fig. 8). Two 32P-labeled
phosphopeptides were isolated. Since the phosphopeptide in
peak 2was immunoreactive with antibody against synthetic
a
peptide that represented the 14 C-terminal amino acid residues of Rex (data not shown), it was identified as the Cterminal chymotryptic peptide, SACTSTSFPPPSPGPSCPT
.(residues 171-189). This and theresults obtained withthe N2 100
B
terminally truncated Rex (Fig. 7) permitted us to postulate
a
that peak 1 should be the chymotryptic peptide containing
n
0
TPA-dependent phosphorylation site(s) within the 78 Nterminal residues. Each 32P-labeled chymotryptic phosphopeptide was mixed with myoglobin as carrierprotein and
subjected to automated Edmandegradation in a spinning cup
50sequenator. Successive degradation and the sequence cycle
number were monitored by analysis of phenylthiohydantoin
amino acids of carrier protein released at cycles 2 and 11. The
amount of radioactivity released during each cycle was monitored by scintillation counting to determine the position(s)
1
I
I
0
of phosphorylated amino acids relative to the amino end of
5
10
15
20
the peptides (Fig. 9). 32Pradioactivity was released during the
Cycle
sixth cycle of peak 1 (Fig. 9A). Only one predicted chymoFIG. 9. Radiosequence analysis. Each chymotryptic phosphotryptic peptide(residues 65-82) contains aserine inthis
peptide from reversed-phase HPLC was subjected to automated Edman degradation as described under “Experimental Procedures.” The position. Moreover, Ser-70 coincides with the consensus seamounts of ’lP radioactivity released during each cycle are shown. A , quence of phosphorylation sites of protein kinase C (Fig. 10).
A similar analysis was used to identify the phosphorylation
peak I in Fig. 8; €3, peak 2 in the same figure.
site(s) of the C-terminalchymotryptic peptide (peak 2 in Fig.
8). In this case, 32Pradioactivity was released at the fourth
this study were to explore the possibility of phosphorylation
and seventh cycles (Fig. 9B). These positions of the chymoin a highly basic N-terminal sequence, MPKTRRRPRRSQtryptic peptide (residues 171-189) (Fig. 10) corresponded to
RKRPPTPWP, which is the nucleolar targeting signalof Rex
Thr-174 and Ser-177, respectively.
(24), and to estimate the TPA-dependent
phosphorylation
site(s), roughly. For this purpose, we constructed theexpresDISCUSSION
sion vectors pKCR27+40X (for full-size Rex) and pKCR21X
In this study, we examined the in vivo phosphorylation of
(for pp21, by deletion of the 78 N-terminal amino acid residues
of Rex) (Fig. 6). After DNA transfection of these expression the HTLV-I posttranscriptional regulator, Rex. Phosphorylvectors into COS-7 cells, the cells were metabolically labeled ation of Rex was observed in all human T-cell lines bearing
with 32Piin the absence or presence of TPA and analyzed by HTLV-I proviruses (HUT-102, MT-2, TL-Su, and TART-1;
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Fig. 2) tested and in COS-7 cells transfected by the Rex editorial assistance and Cheri Rhoderick for preparation of the manexpression vector (Fig. 7, lanes 1 and 2). In every case, the uscript.
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